Trovagene is a precision medical biotech company that works on developing medications for improving cancer care. They do this by using Precision Cancer Monitoring (PCM) technology and their experience in tumor genomics. They use all of this to look at patient’s blood and urine to identify and measure clinical markers that will tell them if the patient is responding to a particular treatment. Precision medicine is a great opportunity for the genetic origin of cancers to be targeted. Treating types of cancer depends on more than just where the cancer originated. It also depends on the genetic and molecular make-up of the tumor. Knowing this make-up can enable the development of treatments that are uniquely tailored to each patient.